-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Vl6wZsj3hPXmDKLNhkGfAMl/ycZ2bAIi3l6N5SEJajIw+CifLIzoEpD6REuPTNxT YCH9WJLo0KTpNqc3/bZ9ag== 0000950157-05-000624.txt : 20060815 0000950157-05-000624.hdr.sgml : 20060815 20050928105805 ACCESSION NUMBER: 0000950157-05-000624 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050928 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WebMD Health Corp. CENTRAL INDEX KEY: 0001326583 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 202783228 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 669 RIVER DR., CENTER 2 CITY: ELMWOOD PARK STATE: NJ ZIP: 07407 BUSINESS PHONE: 201-703-3400 MAIL ADDRESS: STREET 1: 669 RIVER DR., CENTER 2 CITY: ELMWOOD PARK STATE: NJ ZIP: 07407 FORMER COMPANY: FORMER CONFORMED NAME: WebMD Health Holdings, Inc. DATE OF NAME CHANGE: 20050510 CORRESP 1 filename1.htm Amendment No. 6 to Registration Statement on Form S-1


Morgan Stanley & Co. Incorporated
1585 Broadway
New York, New York 10036


September 28, 2005


Securities and Exchange Commission
450 Fifth Street NW
Washington, DC 20549
Attention: Mr. Geoffrey Ossias

Re:
WebMD Health Corp.
 
Amendment No. 6 to Registration Statement on Form S-1
 
(File No. 333-124832)

Dear Mr. Ossias

You have asked that we provide this letter to you in connection with certain changes made in the prospectus for the above-referenced offering, including, without limitation, the increase in the price range for the shares of Class A Common Stock of WebMD Health Corp. being offered. This letter will confirm that Morgan Stanley & Co. Incorporated has, and has been informed by Citigroup Global Markets Inc.; Goldman, Sachs & Co.; and Bear, Stearns & Co. Inc., that each of them has orally advised their sales forces and all prospective purchasers of shares of the change in price range and corresponding changes in the disclosure in the prospectus as a result of such changes.
 
     
  Very truly yours,
   
  Morgan Stanley & Co. Incorporated
 
 		  
 		  
 
  By:   /s/ John Tyree
 
Name: John Tyree
  Title  Executive Director
-----END PRIVACY-ENHANCED MESSAGE-----